Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/306% below fair value
$3.41−0.04 (-1.16%)
Close on Nov 12, 2026Market cap $1.26BP/E 20.1Yield –
Cronos ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cronos's ebitda for the twelve months ending Sep 30, 2026 was $15.22M. For fiscal 2025 it was -$3.16M. The highest annual figure on record is -$3.16M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.16M | – |
| FY2024 | Dec 31, 2024 | -$67.19M | – |
| FY2023 | Dec 31, 2023 | -$76.69M | – |
| FY2022 | Dec 31, 2022 | -$98.31M | – |
| FY2021 | Dec 31, 2021 | -$276.57M | – |
| FY2020 | Dec 31, 2020 | -$212.34M | – |
| FY2019 | Dec 31, 2019 | -$149.05M | – |
| FY2018 | Dec 31, 2018 | -$18.51M | – |
| FY2017 | Dec 31, 2017 | -$5.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.39M | – |
| Q2 FY2026 | Jun 30, 2026 | $7.78M | – |
| Q1 FY2026 | Mar 31, 2026 | $1.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$149.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.23M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.84M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.56M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.22M | – |
| Q4 FY2023 | Dec 31, 2023 | -$20.46M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.32M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.36M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.41M | -121.7% |
| Q3 FY2022 | Sep 30, 2022 | -$25.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$23.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.23M | – |
| Q4 FY2021 | Dec 31, 2021 | $112.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$52.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$293.14M | – |
| Q1 FY2021 | Mar 31, 2021 | -$43.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$56.50M | – |
| Q3 FY2020 | Sep 30, 2020 | -$38.95M | – |
| Q2 FY2020 | Jun 30, 2020 | -$72.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$43.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$94.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$30.07M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.35M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.63M | – |
See a number that looks wrong?